These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 5767441)

  • 21. [Clinical and biological effectiveness of citiolone and importance of its contribution in hepatic therapeutics].
    Duché G
    Therapeutique; 1970 Dec; 46(10):1037-41. PubMed ID: 5511931
    [No Abstract]   [Full Text] [Related]  

  • 22. [Clinical cases on the use of a combination of substances with hepatoprotective and detoxicant action in the treatment of some acute and chronic liver diseases].
    Ivaldi A
    Minerva Med; 1967 Apr; 58(34 Suppl):1618-20. PubMed ID: 4226049
    [No Abstract]   [Full Text] [Related]  

  • 23. [Clinical trial of coenzyme A in hepatopathies].
    Magaraci G
    Minerva Med; 1976 Feb; 67(8):512-8. PubMed ID: 943732
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Experimental liver damage in potassium depletion, inhibited by L-ornithine-L-aspartate.
    Raab WP
    Arzneimittelforschung; 1971 Oct; 21(10):1620-1. PubMed ID: 5171899
    [No Abstract]   [Full Text] [Related]  

  • 25. [1 (+) ornithine alpha ketoglutarate in hepatic encephalopathy].
    Paris J; Merveille P; Molimard R
    Presse Med (1893); 1970 Jun; 78(30):1367-8. PubMed ID: 5421555
    [No Abstract]   [Full Text] [Related]  

  • 26. [Association of vitamins and amino acids in the therapy of chronic liver diseases. Clinical results].
    Miracco A; Orlando V
    Minerva Med; 1967 Apr; 58(34 Suppl):1620-6. PubMed ID: 4226050
    [No Abstract]   [Full Text] [Related]  

  • 27. [Clinico-experimental findings on the use of a new liver protective agent].
    Catalfamo G; Melotti G; Soffritti E
    Minerva Med; 1967 Apr; 58(34 Suppl):1605-12. PubMed ID: 4226047
    [No Abstract]   [Full Text] [Related]  

  • 28. [Recent findings in drug treatment of liver disease patients with ornithine-carbamyl-transferase (OCT). Personal experience].
    Alvisi V; Tralli M; Tampieri ML; Lo Ponte A; D'Ambrosi A
    Minerva Dietol Gastroenterol; 1982; 28(4):335-40. PubMed ID: 7167246
    [No Abstract]   [Full Text] [Related]  

  • 29. [Effects of administration of arginine thiazolidinecarboxylate in liver pathology of various origins. Results of a multicenter study].
    Gasbarrini G; Bernardi M
    Minerva Dietol Gastroenterol; 1982; 28(2):143-52. PubMed ID: 7099448
    [No Abstract]   [Full Text] [Related]  

  • 30. [Clinical study of citiolone, cyto-membranous hepatic protector].
    Varay A; Castel A; Bloch J
    Therapeutique; 1970 Dec; 46(10):993-5. PubMed ID: 5511936
    [No Abstract]   [Full Text] [Related]  

  • 31. [On the therapeutic value of some amino acids in combination with vitamin B 12, folic acid and nicotinamide in the therapy of hepatic insufficiency].
    Meneghini P; Avanzi G
    Minerva Med; 1967 Apr; 58(34 Suppl):1596-603. PubMed ID: 4226045
    [No Abstract]   [Full Text] [Related]  

  • 32. [Treatment of diffuse liver diseases with balanced doses of vitamin B12, folic acid, ascorbic acid and nicotinamide].
    Perez Mota A
    Rev Esp Enferm Apar Dig; 1968; 27(6):933-44. PubMed ID: 4242995
    [No Abstract]   [Full Text] [Related]  

  • 33. [Clinical observations on the therapeutic efficiency of the combination: arginine HCl, citrulline, ornithine HCl, vitamin B-12, folic acid and nicotinamide in liver diseases and in anemic deficiency syndromes].
    Drago U; Finotto E; Ongaro G
    Minerva Med; 1967 Apr; 58(34 Suppl):1592-6. PubMed ID: 4226044
    [No Abstract]   [Full Text] [Related]  

  • 34. [Trofopar treatment of chronic diffuse diseases of the liver].
    Loginov AS; Nikolaeva AP; Bendikov EA; Blok IuE; Sukhareva GV
    Sov Med; 1989; (7):79-81. PubMed ID: 2799537
    [No Abstract]   [Full Text] [Related]  

  • 35. [Clinical study on the treatment of liver disease with glucocorticoids].
    Oda T; Suzuki H; Naito C; Yamanada M; Oka H
    Saishin Igaku; 1969 Oct; 24(10):2119-29. PubMed ID: 5349229
    [No Abstract]   [Full Text] [Related]  

  • 36. [Intravenous administration of ornithine aspartate to patients with hepatic diseases].
    Schäfer W
    Munch Med Wochenschr; 1968 Oct; 110(43):2521-5. PubMed ID: 5755238
    [No Abstract]   [Full Text] [Related]  

  • 37. [Clinical experimentation with Aïcamine in hepatic insufficiency].
    Négret JP
    Bord Med; 1972 Apr; 5(8):973-6. PubMed ID: 5053280
    [No Abstract]   [Full Text] [Related]  

  • 38. [Therapeutic activity of betaine aspartate].
    Nicrosini F
    Clin Ter; 1972 May; 61(3):227-36. PubMed ID: 5050945
    [No Abstract]   [Full Text] [Related]  

  • 39. [Clinical considerations on the use of a new preparation with hepatoprotective action].
    Di Lorenzo S
    Minerva Med; 1967 Apr; 58(34 Suppl):1626-9. PubMed ID: 4226051
    [No Abstract]   [Full Text] [Related]  

  • 40. [On a combination of amino acids and vitamins in the treatment of liver diseases].
    Bazzicalupo G; Pietranera P
    Minerva Med; 1967 Apr; 58(34 Suppl):1587-92. PubMed ID: 4226043
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.